Equities researchers at Wedbush boosted their Q4 2024 earnings per share estimates for Playtika in a research report issued on Wednesday, February 26th. Wedbush analyst M. Pachter now forecasts that ...
Equities researchers at Wedbush raised their FY2024 earnings estimates for shares of Playtika in a report issued on Wednesday, February 26th. Wedbush analyst M. Pachter now forecasts that the company ...
Nvidia executives struck a cautious note on the company’s China business during its quarterly earnings call Wednesday. CEO ...
Wedbush analyst Laura Chico downgraded Praxis Precision (PRAX) to Underperform from Neutral with a price target of $26, down from $57, after ...
Praxis Precision Medicines (PRAX) stock falls amid concerns over success in its late-stage trial for lead asset ulixacaltamide in essential tremor. Read more here.
Super Micro stock plunged more than 25% this week, extending the stock’s long streak of volatility as investors weigh the company’s AI-fueled growth against questionable accounting practices, growing ...
MT Newswires on MSN17h
Williams-Sonoma Likely to Issue Cautious 2025 Outlook Amid Softening Demand Trends, Wedbush SaysWilliams-Sonoma (WSM) is expected to issue a cautious 2025 outlook when it reports fourth-quarter results next month amid softening demand trends for home furnishings goods, Wedbush Securities said in ...
Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback